Dauch Reports Second Quarter 2026 Financial Results
Bullish on a 6–12 month horizon as Dowlais synergies flow through higher EBITDA and cash flow.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish on a 6–12 month horizon as Dowlais synergies flow through higher EBITDA and cash flow.
What happened and why it matters
Dauch reported a strong Q2 2026 driven by the Dowlais acquisition, with $2.96B in sales and solid operating cash flow. The firm raised its 2026 targets to $10.6–$10.8B in revenue and $1.36–$1.425B in Adjusted EBITDA, backed by $60–$75M in synergies and $70–$80M from its China JV. Key questions center on synergy realization and customer demand stability.
The company delivered a strong top-line expansion and robust cash generation, while guiding higher full-year targets and confirming synergy-driven EBITDA upside from the Dowlais acquisition. Historically, such combinations yield short- to mid-term multiple expansion as cash flow and margin improvements become visible; risk lies in execution and macro demand.
Q2 2026 sales $2.96B, up from $1.54B in 2025.
Adjusted EBITDA $389.6M, 13.2% of sales, steady vs prior year.
Net income attributable to Dauch $1.0M; EPS $0.00; Adj EPS $0.32.
Operating cash flow $107.5M; Adjusted free cash flow $148.4M.
Outlook: 2026 revenue $10.6–$10.8B; Adj EBITDA $1.36–$1.425B; synergies $60–$75M.
Earnings; the release centers on Q2 results and refreshed 2026 guidance, including non-GAAP metrics and synergies from the Dowlais deal, which align with investor focus on cash flow and profitability improvements from acquisitions.
More AI-analyzed coverage connected to this story